LIGUORO, DOMENICO
 Distribuzione geografica
Continente #
NA - Nord America 268
EU - Europa 156
AS - Asia 26
SA - Sud America 9
AF - Africa 1
Totale 460
Nazione #
US - Stati Uniti d'America 264
IT - Italia 83
FR - Francia 33
DE - Germania 15
CN - Cina 11
IN - India 8
UA - Ucraina 6
CL - Cile 5
CZ - Repubblica Ceca 5
BR - Brasile 4
CA - Canada 4
NL - Olanda 4
TH - Thailandia 4
GB - Regno Unito 3
BE - Belgio 2
RU - Federazione Russa 2
VN - Vietnam 2
AT - Austria 1
BG - Bulgaria 1
ES - Italia 1
KR - Corea 1
ZA - Sudafrica 1
Totale 460
Città #
Rome 39
Santa Cruz 32
Fairfield 26
Houston 23
Ashburn 19
Woodbridge 17
Seattle 16
Buffalo 13
Cambridge 13
Wilmington 8
Cleveland 6
Shanghai 6
Chicago 5
Mountain View 5
Sirsa 5
Des Moines 4
Milan 4
Ottawa 4
Paris 4
Rogliano 4
Bologna 3
Chiang Mai 3
Gunzenhausen 3
Ann Arbor 2
Avellino 2
Brussels 2
Delhi 2
Glasgow 2
Las Vegas 2
Los Angeles 2
Lucca 2
New York 2
Orléans 2
Provo 2
San Diego 2
University Park 2
Wernigerode 2
Amsterdam 1
Andover 1
Atlanta 1
Auburn 1
Austin 1
Berlin 1
Bloomfield 1
Brescia 1
Büdelsdorf 1
Capannori 1
Chandler 1
Chengdu 1
Cheyenne 1
Crugers 1
Da Nang 1
Dallas 1
Esslingen am Neckar 1
Ho Chi Minh City 1
Hull 1
Hyderabad 1
Jaboatao dos Guararapes 1
Jacksonville 1
Mola di Bari 1
Montegaldella 1
Montpellier 1
Muizenberg 1
Naples 1
Napoli 1
Osimo 1
Parlin 1
Phoenix 1
Portland 1
Recife 1
Riva 1
Saint Louis 1
San Jose 1
Scarsdale 1
Selargius 1
Seoul 1
Sofia 1
Stadtlohn 1
São Paulo 1
Terrassa 1
Trang 1
Vienna 1
Zhongxin 1
Totale 336
Nome #
Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma, file e3835323-e89d-15e8-e053-a505fe0a3de9 150
The promise of liquid biopsy to predict response to immunotherapy in metastatic melanoma, file e383532c-2025-15e8-e053-a505fe0a3de9 94
ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma. Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin, file e3835323-2016-15e8-e053-a505fe0a3de9 91
In vitro biophysical and biological characterization of lipid nanoparticles Co-encapsulating oncosuppressors miR-199b-5p and miR-204-5p as potentiators of target therapy in metastatic melanoma, file e3835325-67ef-15e8-e053-a505fe0a3de9 78
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance, file 8e55545e-645d-4bec-bacd-6bd31bb25a5b 24
miR-579-3p restrains tumor heterogeneity to overcome resistance to target therapies in metastatic melanoma, file e383532e-a3da-15e8-e053-a505fe0a3de9 18
Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma, file 7e211d93-e042-4336-851a-9f88339d5379 7
ERK signaling pathway is constitutively active in NT2D1 non-seminoma cells and its inhibition impairs basal and HGF-activated cell proliferation, file 92e906d2-d9e9-4e36-8736-49e8de271b73 7
miR-125a-5p impairs the metastatic potential in breast cancer via IP6K1 targeting, file e383532d-3c0e-15e8-e053-a505fe0a3de9 6
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma, file e383531d-211c-15e8-e053-a505fe0a3de9 2
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors, file 94c31bdc-35b9-428d-8691-2daaf6b1b538 1
null, file e383532e-cf2a-15e8-e053-a505fe0a3de9 1
Totale 479
Categoria #
all - tutte 1.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.147


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202062 0 0 0 1 6 9 9 10 11 7 6 3
2020/202169 5 7 3 1 10 5 4 4 6 9 12 3
2021/2022135 14 5 5 9 15 5 7 10 11 7 32 15
2022/202391 3 7 27 15 7 12 3 6 3 2 5 1
2023/2024120 4 2 7 24 26 19 11 11 5 11 0 0
Totale 479